HIAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.793200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.764800E-01
Normal-vs-Stage2
2.917400E-01
Normal-vs-Stage3
1.067570E-02
Normal-vs-Stage4
7.800000E-01
Stage1-vs-Stage2
9.855200E-01
Stage1-vs-Stage3
2.128800E-01
Stage1-vs-Stage4
3.530800E-01
Stage2-vs-Stage3
2.253200E-01
Stage2-vs-Stage4
3.406200E-01
Stage3-vs-Stage4
2.611800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.700000E-01
Normal-vs-AfricanAmerican
6.921400E-01
Normal-vs-Asian
1.125830E-01
Caucasian-vs-AfricanAmerican
3.916600E-01
Caucasian-vs-Asian
2.824200E-01
AfricanAmerican-vs-Asian
1.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.410000E-01
Normal-vs-Female
3.509000E-01
Male-vs-Female
1.748410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.720000E-02
Normal-vs-Age(41-60Yrs)
6.536000E-01
Normal-vs-Age(61-80Yrs)
1.946610E-01
Normal-vs-Age(81-100Yrs)
3.281900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.888200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.870200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.910000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.038100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.053690E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.869600E-02
Normal-vs-Daily Drinker
8.384100E-02
Normal-vs-Weekly Drinker
1.098190E-01
Normal-vs-Occasional Drinker
6.514400E-01
Normal-vs-Social Drinker
6.427600E-01
Non Drinker-vs-Daily Drinker
6.418800E-01
Non Drinker-vs-Weekly Drinker
7.829000E-01
Non Drinker-vs-Occasional Drinker
2.025900E-02
Non Drinker-vs-Social Drinker
3.404100E-02
Daily Drinker-vs-Weekly Drinker
9.178600E-01
Daily Drinker-vs-Occasional Drinker
5.305700E-02
Daily Drinker-vs-Social Drinker
6.606100E-02
Weekly Drinker-vs-Occasional Drinker
8.742300E-02
Weekly Drinker-vs-Social Drinker
1.023560E-01
Occasional Drinker-vs-Social Drinker
9.818600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.634800E-01
Normal-vs-Grade 2
6.782500E-02
Normal-vs-Grade 3
8.835600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.274840E-01
Grade 1-vs-Grade 3
3.490800E-01
Grade 1-vs-Grade 4
2.634800E-01
Grade 2-vs-Grade 3
5.494000E-01
Grade 2-vs-Grade 4
6.782500E-02
Grade 3-vs-Grade 4
8.835600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.428250E-01
Normal-vs-NonDiabetic
2.012800E-01
Diabetic-vs-NonDiabetic
4.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.440030E-01
Normal-vs-NoPancreatitis
2.120600E-01
Pancreatitis-vs-NoPancreatitis
9.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.115000E-01
Normal-vs-N1
2.894400E-01
N0-vs-N1
8.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.595200E-01
Normal-vs-TP53-NonMutant
3.934800E-01
TP53-Mutant-vs-TP53-NonMutant
6.263400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
